Jushi Holdings JUSHF
OTC JUSHF
$0.42 +0.01 (+2.44%)
At close: Aug 7, 2026 · 4:00 PM UTC

Jushi Holdings (JUSHF) Net Income towards Common Stockholders (2021 - 2026)

Jushi Holdings (JUSHF) posted quarterly Net Income towards Common Stockholders of -$7.3 million for Q2 2026, up 40.56% year-over-year from -$5.2 million in Q2 2025, and up 63.07% quarter-over-quarter from -$19.8 million in Q1 2026.

Jushi Holdings (JUSHF) Net Income towards Common Stockholders (2021 - 2026) Analysis & Trends

Jushi Holdings (JUSHF) has reported Net Income towards Common Stockholders for 6 consecutive years, with -$7.3 million the latest figure, recorded in Q2 2026.

  • In Q2 2026, Net Income towards Common Stockholders rose 40.56% year-over-year to -$7.3 million; the TTM figure through Jun 2026 stood at -$66.4 million (down 14.86% YoY), while the FY2025 annual figure was -$68.6 million, down 40.62% from the prior year.
  • Net Income towards Common Stockholders rose to -$7.3 million in Q2 2026 per JUSHF's latest filing, from -$19.8 million in the prior quarter.
  • Across five years, Net Income towards Common Stockholders topped out at $12.1 million in Q2 2022 and bottomed at -$139.9 million in Q4 2022.
  • Historically, Net Income towards Common Stockholders has averaged -$22.9 million across 5 years, with a median of -$16.5 million in 2024.
  • On a YoY basis, Net Income towards Common Stockholders climbed as much as 357.74% in 2022 and fell as far as 2353.05% in 2022.
  • Jushi Holdings' Net Income towards Common Stockholders stood at -$139.9 million in 2022, then soared by 87.13% to -$18.0 million in 2023, then soared by 30.75% to -$12.5 million in 2024, then declined by 24.77% to -$15.6 million in 2025, then jumped by 52.89% to -$7.3 million in 2026.
  • Business Quant data shows JUSHF's Net Income towards Common Stockholders at -$7.3 million in Q2 2026, -$19.8 million in Q1 2026, and -$15.6 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Haleon 43.81 Bn 42.84 Bn - -
2 Teva Pharmaceutical Industries 43.29 Bn 39.63 Bn 2.15 Bn -576.00 Mn
3 Zoetis 31.59 Bn 29.91 Bn 1.05 Bn 866.00 Mn
4 Takeda Pharmaceutical 28.67 Bn 22.88 Bn 5.10 Bn 710.19 Mn
5 United Therapeutics 22.24 Bn 19.58 Bn 683.80 Mn 333.00 Mn
6 Viatris 18.79 Bn 17.91 Bn 1.46 Bn -118.80 Mn
7 Neurocrine Biosciences 15.71 Bn 15.32 Bn 935.80 Mn 144.40 Mn
8 Elanco Animal Health 12.09 Bn 11.56 Bn 798.00 Mn 54.00 Mn
9 Dr Reddys Laboratories 10.11 Bn 9.95 Bn - -
10 Jushi Holdings 83.87 Mn 50.54 Mn 31.53 Mn -7.33 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -7.33 Mn
Mar 31, 2026 -19.85 Mn
Dec 31, 2025 -15.56 Mn
Sep 30, 2025 -23.69 Mn
Jun 30, 2025 -12.33 Mn
Mar 31, 2025 -17.02 Mn
Dec 31, 2024 -12.47 Mn
Sep 30, 2024 -16.02 Mn
Jun 30, 2024 -1.94 Mn
Mar 31, 2024 -18.36 Mn
Dec 31, 2023 -18.00 Mn
Sep 30, 2023 -20.62 Mn
Jun 30, 2023 -14.04 Mn
Mar 31, 2023 -12.44 Mn
Dec 31, 2022 -139.94 Mn
Sep 30, 2022 -54.70 Mn
Jun 30, 2022 12.07 Mn
Mar 31, 2022 -19.76 Mn
Dec 31, 2021 6.21 Mn
Sep 30, 2021 39.68 Mn